Kerendia 10 mg film coated tablets clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
Effects of Finerenone on Renal Hemodynamics and Oxidative Stress
This study is looking at how a medicine called Kerendia (finerenone) affects the kidneys in people with type 2 diabetes. It aims to see if Kerendia can help improve kidney function by reducing stress on kidney blood vessels, compared to a dummy pill.
For: type 2 diabetes mellitusGermany - Ongoing, recruitingTherapeutic use (Phase IV)
Optimization of Albuminuria-Lowering Therapies for Individual Patients with Type 2 Diabetes Using Empagliflozin and Finerenone in a Pilot Remote Clinical Trial
This study looks at how well different diabetes medicines work together to protect kidneys in people with type 2 diabetes. It also checks how easy it is for people to take part in a study from home using digital tools, like giving urine samples and checking blood pressure.
For: Albuminuria · Type 2 diabetesNetherlands - Ongoing, recruitingTherapeutic exploratory (Phase II)
(21839) A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in participants with chronic kidney disease and type 2 diabetes.
This study is looking at how two medicines, finerenone (Kerendia) and empagliflozin (Jardiance), affect people with chronic kidney disease and type 2 diabetes. We want to see if using both together is better than using just one in improving kidney health.
For: Chronic kidney disease in type 2 diabetes mellitusItaly · France · Netherlands